PDGFC and gastrointestinal stromal tumor: Finally, gedatolisib treatment (50 nM for 24 h) of CAFs significantly decreased PDGFC mRNA expression (Supplementary Fig. 6h), suggesting that gedatolisib regulates the paracrine crosstalk between CAFs and GIST at the transcriptional and intracellular signaling levels.